Antibiotherapy of Serratia marcescens septicemia in children. 1977

F Baquero, and J G Hortelano, and M Navarro, and A Scarpellini, and P Jara, and T Cañedo, and A Rodríguez

The clinical and bacteriological response of 38 treatments performed on 24 children (11 of them neonates) carrying out separate treatments with carbenicillin (2 treatments), gentamicin [4], fosfomycin [6], and associated treatments with gentamicin plus carbenicillin [6], fosfomycin plus gentamicin [18] and fosfomycin plus carbenicillin [2] are considered. The clinical cure was obtained in 21 children (87.5%). The most effective treatment was fosfomycin plus gentamicin; both antibiotics showed synergism in vitro on isolated Serratia strains. A dosage of 75 mg/kg fosfomycin enables serum levels of about 32 mug/ml during 4-5 h, being this level higher to the MIC of all isolated strains of S. marcescens.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002228 Carbenicillin Broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function. Carboxybenzyl Penicillin,Anabactyl,Carbapen,Carbecin,Carbenicillin Disodium,Geopen,Microcillin,Pyopen,Disodium, Carbenicillin,Penicillin, Carboxybenzyl
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004756 Enterobacteriaceae Infections Infections with bacteria of the family ENTEROBACTERIACEAE. Enterobacterial Infections,Cronobacter Infections,Infections, Enterobacteriaceae,Infections, Enterobacterial,Cronobacter Infection,Enterobacteriaceae Infection,Enterobacterial Infection,Infection, Cronobacter,Infection, Enterobacteriaceae,Infection, Enterobacterial,Infections, Cronobacter
D005260 Female Females
D005578 Fosfomycin An antibiotic produced by Streptomyces fradiae. Phosphonomycin,Fosfomycin Trometamol Salt,Fosfomycin Tromethamine,Monuril,Phosphomycin,Tromethamine, Fosfomycin

Related Publications

F Baquero, and J G Hortelano, and M Navarro, and A Scarpellini, and P Jara, and T Cañedo, and A Rodríguez
February 1968, Archives of internal medicine,
F Baquero, and J G Hortelano, and M Navarro, and A Scarpellini, and P Jara, and T Cañedo, and A Rodríguez
November 1965, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
F Baquero, and J G Hortelano, and M Navarro, and A Scarpellini, and P Jara, and T Cañedo, and A Rodríguez
March 1993, Transfusion,
F Baquero, and J G Hortelano, and M Navarro, and A Scarpellini, and P Jara, and T Cañedo, and A Rodríguez
August 1964, Acta medica Scandinavica,
F Baquero, and J G Hortelano, and M Navarro, and A Scarpellini, and P Jara, and T Cañedo, and A Rodríguez
October 1988, Presse medicale (Paris, France : 1983),
F Baquero, and J G Hortelano, and M Navarro, and A Scarpellini, and P Jara, and T Cañedo, and A Rodríguez
April 1967, Bulletins et memoires de la Societe medicale des hopitaux de Paris,
F Baquero, and J G Hortelano, and M Navarro, and A Scarpellini, and P Jara, and T Cañedo, and A Rodríguez
January 2009, Indian pediatrics,
F Baquero, and J G Hortelano, and M Navarro, and A Scarpellini, and P Jara, and T Cañedo, and A Rodríguez
July 1963, The Journal of urology,
F Baquero, and J G Hortelano, and M Navarro, and A Scarpellini, and P Jara, and T Cañedo, and A Rodríguez
February 1963, Gazette medicale de France,
F Baquero, and J G Hortelano, and M Navarro, and A Scarpellini, and P Jara, and T Cañedo, and A Rodríguez
February 1970, New York state journal of medicine,
Copied contents to your clipboard!